Octarine receives funding to develop biosynthetic platform for cannabinoid and psilocybin derivatives

Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…

Read more

Cannabis thérapeutique : un fonds veut doper l’écosystème européen

Oskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…

Read more

Medical cannabis private equity fund established

Ireland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…

Read more

Central Bank signs off on €150m legal cannabis fund

THE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…

Read more

Broughton bids farewell to Mercia

Mercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…

Read more


The Medical Cannabis Opportunity in the EU Stimulus Package

The good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…

Read more

Media contact details